|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Ovation Research Group Genentech |
|---|---|
| Information provided by: | Ovation Research Group |
| ClinicalTrials.gov Identifier: | NCT00350376 |
Purpose
The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.
| Condition |
|---|
|
Asthma Allergies |
| Study Type: | Observational |
| Study Design: | Cross-Sectional, Defined Population, Retrospective Study |
| Official Title: | Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR) |
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Contacts and Locations| Contact: Nita Ngo, MPH | 888.631.9167 | asthmastudy@ovation.org |
| United States, California | |
| Ovation Research Group | Recruiting |
| San Francisco, California, United States, 94105 | |
| Principal Investigator: Susan D Mathias, MPH | |
| Principal Investigator: | Susan D Mathias, MPH | Ovation Research Group |
More Information
| Study ID Numbers: | 1467 |
| Study First Received: | July 5, 2006 |
| Last Updated: | July 5, 2006 |
| ClinicalTrials.gov Identifier: | NCT00350376 |
| Health Authority: | United States: Institutional Review Board |
|
asthma allergies Xolair Advair |
|
Lung Diseases, Obstructive Hypersensitivity Respiratory Tract Diseases Lung Diseases |
Hypersensitivity, Immediate Asthma Omalizumab Respiratory Hypersensitivity |
|
Immune System Diseases Bronchial Diseases |
